COLUMBIA LABORATORIES INC (CBRX) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 178 transactions totaling $19.5M, demonstrating a bearish sentiment with -$18.7M in net insider flow. The most recent transaction on Nov 20, 2014 involved a purchase of 1,000 shares valued at $6.0K.
No significant insider buying has been recorded for CBRX in the recent period.
No significant insider selling has been recorded for CBRX in the recent period.
Based on recent SEC filings, insider sentiment for CBRX is bearish with an Insider Alignment Score of 2/100 and a net flow of -$18.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at COLUMBIA LABORATORIES INC (CBRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading CBRX stock, having executed 178 transactions in the past 90 days. The most active insider is Plc Actavis (Executive), who has made 1 transactions totaling $8.5M.
Get notified when executives and directors at CBRX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 20, 2014 | H. Hunter Donald | Executive | Purchase | 1,000 | $5.98 | $6.0K | |
| Aug 13, 2014 | Condella Frank Jr | Executive | Purchase | 10,000 | $5.98 | $59.8K | |
| May 8, 2014 | H. Hunter Donald | Executive | Award | 4,566 | $N/A | $0 | |
| May 8, 2014 | M. Armstrong Frank | Executive | Award | 4,566 | $N/A | $0 | |
| May 8, 2014 | G. Kasnet Stephen | Executive | Award | 4,566 | $N/A | $0 | |
| May 8, 2014 | G. Kasnet Stephen | Executive | Payment | 2,419 | $6.57 | $15.9K | |
| May 8, 2014 | Csimma Cristina | Executive | Payment | 2,117 | $6.57 | $13.9K | |
| May 8, 2014 | Csimma Cristina | Executive | Award | 4,566 | $N/A | $0 | |
| May 8, 2014 | A. Blechschmidt Edward | Executive | Payment | 3,024 | $6.57 | $19.9K | |
| May 8, 2014 | Lynne Andrews Valerie | Executive | Award | 4,566 | $N/A | $0 | |
| May 8, 2014 | Lynne Andrews Valerie | Executive | Payment | 3,024 | $6.57 | $19.9K | |
| May 5, 2014 | Jonathan Brian Lloyd Jones | Executive | Option Exercise | 1,000 | $5.04 | $5.0K | |
| May 5, 2014 | Condella Frank Jr | Executive | Purchase | 10,000 | $6.65 | $66.5K | |
| Mar 11, 2014 | Jonathan Brian Lloyd Jones | Executive | Option Exercise | 2,000 | $5.04 | $10.1K | |
| Mar 7, 2014 | Llc Coventry Acquisition, | Executive | Sale | 1,400,000 | $5.76 | $8.1M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 12 | $19.1M | 94.8% |
Payment(F) | 73 | $522.5K | 2.6% |
Purchase(P) | 14 | $430.2K | 2.1% |
Conversion(C) | 3 | $47.5K | 0.2% |
Award(A) | 68 | $39.5K | 0.2% |
Exercise(M) | 2 | $15.1K | 0.1% |
Other(J) | 6 | $0 | 0.0% |
Insider selling pressure at COLUMBIA LABORATORIES INC has increased, with 22 insiders executing 178 transactions across all time. Total sales of $19.1M significantly outpace purchases of $430.2K, resulting in a net outflow of $18.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.